We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


LSGPA Invests $250,000 in SoftGenetics

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

The Life Sciences Greenhouse of Central Pennsylvania (LSGPA) has announced an investment of $250,000 in SoftGenetics, LLC.

The funds will be used to accelerate development of the company's "MicroArray Copy Number and SNP Chip" software.

It's widely believed that the ability to pinpoint variation in SNPs is the first step toward identifying susceptibility to or causes of certain diseases.

"If the promise of personalized medicine is to be realized, today's researchers and diagnosticians need access to highly sensitive, highly accurate tools that are also fast and easy to use," says SoftGenetics V.P. of Development, Dr. C.S. Liu.

"With this funding we intend to leverage our existing expertise in mutation detection and software design to deliver to the research and medical communities precisely the tool they've been clamoring for."

Dr. Mel Billingsley, President & CEO of LSGPA, noted that the importance of genetics-based diagnosis and treatments has been on the rise as the human genome has been sequenced.

"As both a researcher and an investor, it's exciting to be involved with a company working at the confluence of information technology and healthcare."

"The scientific community has just begun to exploit the potential of molecular diagnostics, but we can be certain that the field will have significant impact on the quality of patient care."